FRANCE-2 Risk Model (TAVR) Calculator

Clinical calculation support · Verify results before clinical use

Patient risk factors

Enter pre-procedural characteristics. This historical model estimates early mortality after TAVR; verify the provisional scoring implementation before clinical use.

—Score
NYHA functional class IV

Severe symptoms at rest or with minimal activity

+3 points
Pulmonary hypertension

Systolic pulmonary artery pressure ≥60 mmHg

+2 points
Critical haemodynamic state

Use the definition from the original FRANCE-2 study

+3 points
At least 2 episodes of pulmonary oedema in the previous year

Before TAVR

+2 points
Respiratory insufficiency

As defined in the original FRANCE-2 study

+2 points
Dialysis

Currently receiving dialysis

+4 points
Non-transfemoral approach

For example, transapical or another non-transfemoral access; route-specific weighting requires verification

+2 points

About the FRANCE-2 model

The FRANCE-2 score was developed using registry data to estimate 30-day or in-hospital mortality after transcatheter aortic valve implantation (TAVI/TAVR). The derivation and validation cohorts included 3,833 patients in total.

Variables included

VariableCriterionPoints used by this calculator
Age≥90 years3
BMI≤18.5 kg/m²3
NYHA functional class IVSevere symptoms at rest or with minimal activity3
Pulmonary hypertensionSystolic pulmonary artery pressure ≥60 mmHg2
Critical haemodynamic stateUse the definition from the original FRANCE-2 study3
At least 2 episodes of pulmonary oedema in the previous yearBefore TAVR2
Respiratory insufficiencyAs defined in the original FRANCE-2 study2
DialysisCurrently receiving dialysis4
Non-transfemoral approachFor example, transapical or another non-transfemoral access; route-specific weighting requires verification2

Important limitations

  • The published discrimination was modest (C-index approximately 0.67 in derivation and 0.59 in validation).
  • The model was derived from an earlier-generation TAVI cohort; contemporary devices, access strategies, and patient selection may differ.
  • Frailty and several dimensions of functional status are not included in this score.

Reference

Iung B, Laouénan C, Himbert D, et al.
Predictive factors of early mortality after transcatheter aortic valve implantation: Individual risk assessment using a simple score. Heart. 2014;100(13):1016–1023.
doi:10.1136/heartjnl-2013-305314
PubMed: 24740804

The BMI threshold and access-route categories have been aligned with descriptions of the published FRANCE-2 model. Other point assignments and the mortality bands inherited from the supplied implementation have not been fully reconciled against the original scoring table; do not use this calculator for clinical decisions until those elements are verified.

Clinical disclaimer: This calculator is intended for educational and decision-support use. It does not replace contemporary guideline-based assessment, patient-specific judgement, or multidisciplinary Heart Team discussion. Important: the remaining point assignments and mortality bands require verification against the original publication before clinical use. This implementation should be treated as provisional and must not be used as a stand-alone clinical decision tool.